Aspira Women's Health Inc.
AWHL- Exchange
- OTC
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0000926617
No open-market purchases or sales by Aspira Women's Health Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Aspira Women's Health Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Of which not filed for Q3 2022 | Q3 2022 | Change |
|---|---|---|---|---|
| Holders | 72 | 1 | 58 | −13 |
| Shares | 11.9M | 630.5K | 12.0M | +678.0K (+6.0%) |
| Value | $7.02M | $370.0K | $4.46M | −$2.19M (−32.9%) |
1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (8)
Institutions that held Aspira Women's Health Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Sabby Management, LLC | 1,569,782 | $584.0K | 1.27% |
| National Asset Management, Inc. | 682,469 | $255.0K | 0.01% |
| Perkins Capital Management Inc | 200,000 | $74.0K | 0.08% |
| Man Group plc | 23,509 | $9.00K | 0.00% |
| Castleview Partners, LLC | 19,750 | $7.00K | 0.01% |
| Two Sigma Securities, LLC | 16,903 | $6.00K | 0.00% |
| Warberg Asset Management LLC | 15,000 | $6.00K | 0.00% |
| BNP Paribas Arbitrage, SA | 11,562 | $4.30K | 0.00% |
Sold out (21)
Institutions that held Aspira Women's Health Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| White Pine Capital LLC | 125,000 | $73.0K |
| HRT Financial LP | 121,634 | $71.0K |
| D. E. Shaw & Co., Inc. | 88,709 | $52.0K |
| Deutsche Bank AG | 71,818 | $42.0K |
| Susquehanna International Group, LLP | 45,292 | $27.0K |
| Private Advisor Group, LLC | 43,319 | $26.0K |
| Sawtooth Solutions, LLC | 42,119 | $25.0K |
| Gsa Capital Partners LLP | 36,152 | $21.0K |
| Virtu Financial LLC | 36,330 | $21.0K |
| Y-Intercept (Hong Kong) Ltd | 28,463 | $17.0K |
| Griffin Asset Management, Inc. | 18,000 | $11.0K |
| Brinker Capital Investments, LLC | 18,472 | $11.0K |
| Orion Portfolio Solutions, LLC | 17,219 | $10.0K |
| Balyasny Asset Management LLC | 13,985 | $8.00K |
| Moors & Cabot, Inc. | 10,000 | $6.00K |
| GWM Advisors LLC | 10,000 | $6.00K |
| Citigroup Inc | 8,741 | $5.00K |
| Captrust Financial Advisors | 1,874 | $1.00K |
| New York State Common Retirement Fund | 604 | $0 |
| Simplex Trading, LLC | 56 | $0 |
| Capital Advisors, Ltd. LLC | 271 | $0 |
Not filed for Q3 2022 yet (1)
Institutions that held Aspira Women's Health Inc. at the end of Q2 2022 and haven't filed a 13F for Q3 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| B. Riley Wealth Management, Inc. | 630,520 | $370.0K |